These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10331412)

  • 1. Plasma and interstitial glucose dynamics after intravenous glucose injection: evaluation of the single-compartment glucose distribution assumption in the minimal models.
    Regittnig W; Trajanoski Z; Leis HJ; Ellmerer M; Wutte A; Sendlhofer G; Schaupp L; Brunner GA; Wach P; Pieber TR
    Diabetes; 1999 May; 48(5):1070-81. PubMed ID: 10331412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic modeling of the intravenous glucose tolerance test in type 2 diabetes: a new approach to the insulin compartment.
    Ward GM; Walters JM; Barton J; Alford FP; Boston RC
    Metabolism; 2001 May; 50(5):512-9. PubMed ID: 11319711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epinephrine effects on insulin-glucose dynamics: the labeled IVGTT two-compartment minimal model approach.
    Vicini P; Avogaro A; Spilker ME; Gallo A; Cobelli C
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E78-84. PubMed ID: 12067846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian two-compartment and classic single-compartment minimal models: comparison on insulin modified IVGTT and effect of experiment reduction.
    Callegari T; Caumo A; Cobelli C
    IEEE Trans Biomed Eng; 2003 Dec; 50(12):1301-9. PubMed ID: 14656059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hot IVGTT two-compartment minimal model: indexes of glucose effectiveness and insulin sensitivity.
    Vicini P; Caumo A; Cobelli C
    Am J Physiol; 1997 Nov; 273(5):E1024-32. PubMed ID: 9374690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility and comparability of insulin sensitivity indices measured by stable-label intravenous glucose tolerance test.
    Hovorka R; Bannister P; Eckland DJ; Halliday D; Murley DN; Rees SE; Young MA
    Diabet Med; 1998 Mar; 15(3):234-46. PubMed ID: 9545125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods.
    Kjems LL; Vølund A; Madsbad S
    Diabetologia; 2001 Oct; 44(10):1339-48. PubMed ID: 11692185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT.
    Cobelli C; Pacini G; Toffolo G; Saccà L
    Am J Physiol; 1986 May; 250(5 Pt 1):E591-8. PubMed ID: 3518490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodological issues in the application of the minimal model: effects of glucose dose, basal glucose concentration, test duration and modelling constraint.
    Godsland IF; Luzio S; Wynn V; Owens DR
    Diabetes Res; 1994; 26(4):139-53. PubMed ID: 7648789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overestimation of minimal model glucose effectiveness in presence of insulin response is due to undermodeling.
    Cobelli C; Bettini F; Caumo A; Quon MJ
    Am J Physiol; 1998 Dec; 275(6):E1031-6. PubMed ID: 9843746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reassessment of glucose effectiveness and insulin sensitivity from minimal model analysis: a theoretical evaluation of the single-compartment glucose distribution assumption.
    Ni TC; Ader M; Bergman RN
    Diabetes; 1997 Nov; 46(11):1813-21. PubMed ID: 9356031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.
    Polonsky KS; Licinio-Paixao J; Given BD; Pugh W; Rue P; Galloway J; Karrison T; Frank B
    J Clin Invest; 1986 Jan; 77(1):98-105. PubMed ID: 3511094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hot but not the cold minimal model allows precise assessment of insulin sensitivity in NIDDM subjects.
    Avogaro A; Vicini P; Valerio A; Caumo A; Cobelli C
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E532-40. PubMed ID: 8638702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal models of glucose disappearance: lessons from the labelled IVGTT.
    Caumo A; Giacca A; Morgese M; Pozza G; Micossi P; Cobelli C
    Diabet Med; 1991 Nov; 8(9):822-32. PubMed ID: 1837509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis.
    Mari A
    Diabetologia; 1998 Sep; 41(9):1029-39. PubMed ID: 9754821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates.
    Finegood DT; Bergman RN; Vranic M
    Diabetes; 1987 Aug; 36(8):914-24. PubMed ID: 3297886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative indexes of beta-cell function during graded up&down glucose infusion from C-peptide minimal models.
    Toffolo G; Breda E; Cavaghan MK; Ehrmann DA; Polonsky KS; Cobelli C
    Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E2-10. PubMed ID: 11120653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic glucose production during the labeled IVGTT: estimation by deconvolution with a new minimal model.
    Caumo A; Cobelli C
    Am J Physiol; 1993 May; 264(5 Pt 1):E829-41. PubMed ID: 8498505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated model of hepatic and peripheral glucose regulation for estimation of endogenous glucose production during the hot IVGTT.
    Krudys KM; Dodds MG; Nissen SM; Vicini P
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E1038-46. PubMed ID: 15632105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose effectiveness and insulin sensitivity from the minimal models: consequences of undermodeling assessed by Monte Carlo simulation.
    Vicini P; Caumo A; Cobelli C
    IEEE Trans Biomed Eng; 1999 Feb; 46(2):130-7. PubMed ID: 9932334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.